2019
Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II
Inohara T, Shrader P, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Go AS, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP, Patients and Investigators O. Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II. American Heart Journal 2019, 213: 81-90. PMID: 31129441, DOI: 10.1016/j.ahj.2019.04.007.Peer-Reviewed Original ResearchMeSH KeywordsAgedAnticoagulantsAtrial FibrillationCardiovascular DiseasesCoronary Artery DiseaseDrug Therapy, CombinationFactor Xa InhibitorsFemaleHemorrhageHumansMaleMiddle AgedMyocardial InfarctionMyocardial RevascularizationPeripheral Arterial DiseasePlatelet Aggregation InhibitorsProportional Hazards ModelsProspective StudiesRegistriesStrokeTreatment OutcomeWarfarinConceptsNew-onset atrial fibrillationDirect oral anticoagulantsConcomitant antiplatelet therapyPeripheral artery diseaseAtrial fibrillationVascular diseaseAntiplatelet therapyMajor bleedingArtery diseaseMyocardial infarctionORBIT-AF II registryAtrial Fibrillation IIImproved cardiovascular outcomesVascular disease patientsProportional hazards modelOutcomes of individualsOral anticoagulationCardiovascular outcomesOral anticoagulantsTriple therapyMost patientsPatient characteristicsCoronary diseaseDual therapyNeurological events
2015
Feasibility of Extended Ambulatory Electrocardiogram Monitoring to Identify Silent Atrial Fibrillation in High‐risk Patients: The Screening Study for Undiagnosed Atrial Fibrillation (STUDY‐AF)
Turakhia MP, Ullal AJ, Hoang DD, Than CT, Miller JD, Friday KJ, Perez MV, Freeman JV, Wang PJ, Heidenreich PA. Feasibility of Extended Ambulatory Electrocardiogram Monitoring to Identify Silent Atrial Fibrillation in High‐risk Patients: The Screening Study for Undiagnosed Atrial Fibrillation (STUDY‐AF). Clinical Cardiology 2015, 38: 285-292. PMID: 25873476, PMCID: PMC4654330, DOI: 10.1002/clc.22387.Peer-Reviewed Original ResearchConceptsAT/AFSilent atrial fibrillationSupraventricular ectopic complexesAtrial fibrillationAtrial tachycardiaEctopic complexesRisk factorsContinuous ambulatory electrocardiographic monitoringDevelopment of AFPrior atrial fibrillationTransient ischemic attackAsymptomatic atrial fibrillationHigh-risk patientsProspective screening studyAmbulatory electrocardiographic monitoringUndiagnosed atrial fibrillationContinuous ambulatory ECG monitoringCombined diagnostic yieldScreening studyAmbulatory electrocardiogram monitoringAmbulatory ECG monitoringIschemic attackCoronary diseaseHeart failureElectrocardiographic monitoring
2009
Statin Use and Ventricular Arrhythmias During Clinical Treadmill Testing
DEWEY FE, PEREZ M, HADLEY D, FREEMAN JV, WANG P, ASHLEY EA, MYERS J, FROELICHER VF. Statin Use and Ventricular Arrhythmias During Clinical Treadmill Testing. Journal Of Cardiovascular Electrophysiology 2009, 20: 193-199. PMID: 18775041, DOI: 10.1111/j.1540-8167.2008.01284.x.Peer-Reviewed Original ResearchConceptsFrequent premature ventricular complexesPremature ventricular complexesStatin useVentricular arrhythmiasCoronary diseaseTreadmill testingLower oddsExercise-induced ventricular arrhythmiasPropensity-adjusted logistic regressionsVA Palo Alto Health Care SystemClinical treadmill testingPrior coronary diseaseExercise treadmill testingExercise-induced anginaCoronary artery diseasePropensity score adjustmentHealth care systemPVC rateExercise capacityArtery diseaseAdverse prognosisFree patientsReduced oddsVentricular complexesStudy population